CFGS

Concourse Financial Group Securities Portfolio holdings

AUM $1.77B
1-Year Est. Return 17.35%
This Quarter Est. Return
1 Year Est. Return
+17.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$87.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11,860
New
Increased
Reduced
Closed

Top Buys

1 +$4.85M
2 +$3.93M
3 +$3.71M
4
MBB icon
iShares MBS ETF
MBB
+$3.54M
5
BINC icon
BlackRock Flexible Income ETF
BINC
+$3.48M

Sector Composition

1 Technology 9.19%
2 Financials 5.6%
3 Industrials 4%
4 Consumer Discretionary 3.93%
5 Healthcare 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAKAW
3076
DELISTED
Kindly MD, Inc. Warrants
NAKAW
0
SECR
3077
IQ MacKay Securitized Income ETF
SECR
$157M
0
SMTK
3078
SmartKem
SMTK
$5.52M
0
CPNJ
3079
Calamos Nasdaq-100 Structured Alt Protection ETF - June
CPNJ
$27.1M
0
EQIN
3080
Columbia U.S. Equity Income ETF
EQIN
$261M
0
GARP
3081
iShares MSCI USA Quality GARP ETF
GARP
$1.17B
0
INEQ
3082
Columbia International Equity Income ETF
INEQ
$53.1M
0
JNEU
3083
AllianzIM U.S. Equity Buffer15 Uncapped June ETF
JNEU
$26.8M
0
JUNP
3084
PGIM US Large-Cap Buffer 12 ETF - June
JUNP
$24.6M
0
KJUN
3085
Innovator U.S. Small Cap Power Buffer ETF - June
KJUN
$18.5M
0
NJUN
3086
Innovator Growth-100 Power Buffer ETF - June
NJUN
$66.6M
0
PBJN
3087
PGIM US Large-Cap Buffer 20 ETF - June
PBJN
$20.7M
0
RTRE
3088
Rareview Total Return Bond ETF
RTRE
$53.2M
0
AIPI
3089
REX AI Equity Premium Income ETF
AIPI
$411M
0
RSSL
3090
Global X Russell 2000 ETF
RSSL
$1.48B
0
FLYE
3091
Fly-E Group
FLYE
$11.3M
0
GAUZ
3092
Gauzy
GAUZ
$20.1M
0
LIF
3093
Life360
LIF
$4.3B
0
QXO
3094
QXO Inc
QXO
$17B
0
CHEB.U
3095
DELISTED
Chenghe Acquisition II Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
CHEB.U
0
DSYWW
3096
Big Tree Cloud Holdings Warrant
DSYWW
$137K
0
DSY
3097
Big Tree Cloud Holdings
DSY
$26M
0
ETHD
3098
ProShares UltraShort Ether ETF
ETHD
$85.8M
0
ETHT
3099
ProShares Ultra Ether ETF
ETHT
$300M
0
RAPP
3100
Rapport Therapeutics
RAPP
$1.33B
0